BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 36338891)

  • 1. Effects of COVID-19 on the liver: The experience of a single center.
    Liakina V; Stundiene I; Milaknyte G; Bytautiene R; Reivytyte R; Puronaite R; Urbanoviciute G; Kazenaite E
    World J Gastroenterol; 2022 Oct; 28(39):5735-5749. PubMed ID: 36338891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study.
    Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Lin WB; Zhang GQ; Li GT; Cui GL; Wang FS
    BMC Infect Dis; 2021 Aug; 21(1):818. PubMed ID: 34399709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network.
    Hundt MA; Deng Y; Ciarleglio MM; Nathanson MH; Lim JK
    Hepatology; 2020 Oct; 72(4):1169-1176. PubMed ID: 32725890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Biochemistries in Hospitalized Patients With COVID-19.
    Bloom PP; Meyerowitz EA; Reinus Z; Daidone M; Gustafson J; Kim AY; Schaefer E; Chung RT
    Hepatology; 2021 Mar; 73(3):890-900. PubMed ID: 32415860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic and gastrointestinal disturbances in Egyptian patients infected with coronavirus disease 2019: A multicentre cohort study.
    Shousha HI; Afify S; Maher R; Asem N; Fouad E; Mostafa EF; Medhat MA; Abdalazeem A; Elmorsy H; Aziz MM; Mohammed RS; Ibrahem M; Elgarem H; Omran D; Hassany M; Elsayed B; Abdelaziz AY; El Kassas M
    World J Gastroenterol; 2021 Oct; 27(40):6951-6966. PubMed ID: 34790017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19.
    Higuera-de la Tijera F; Servín-Caamaño A; Reyes-Herrera D; Flores-López A; Robiou-Vivero EJA; Martínez-Rivera F; Galindo-Hernández V; Chapa-Azuela O; Chávez-Morales A; Rosales-Salyano VH
    Liver Res; 2021 Mar; 5(1):21-27. PubMed ID: 33520337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal liver tests in patients with SARS-CoV-2 or influenza - prognostic similarities and temporal disparities.
    Shafran N; Issachar A; Shochat T; Shafran IH; Bursztyn M; Shlomai A
    JHEP Rep; 2021 Jun; 3(3):100258. PubMed ID: 33644724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.
    Kumar-M P; Mishra S; Jha DK; Shukla J; Choudhury A; Mohindra R; Mandavdhare HS; Dutta U; Sharma V
    Hepatol Int; 2020 Sep; 14(5):711-722. PubMed ID: 32623633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Involvement during SARS-CoV-2 Infection Is Associated with a Worse Respiratory Outcome in COVID-19 Patients.
    Romano C; Cozzolino D; Nevola R; Abitabile M; Carusone C; Cinone F; Cuomo G; Nappo F; Sellitto A; Umano GR; Adinolfi LE; Marrone A; Rinaldi L
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated liver enzymes portends a higher rate of complication and death in SARS-CoV-2.
    Currier EE; Dabaja M; Jafri SM
    World J Hepatol; 2021 Sep; 13(9):1181-1189. PubMed ID: 34630884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis.
    Sharma A; Jaiswal P; Kerakhan Y; Saravanan L; Murtaza Z; Zergham A; Honganur NS; Akbar A; Deol A; Francis B; Patel S; Mehta D; Jaiswal R; Singh J; Patel U; Malik P
    Ann Hepatol; 2021; 21():100273. PubMed ID: 33075578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients.
    Krishnan A; Prichett L; Tao X; Alqahtani SA; Hamilton JP; Mezey E; Strauss AT; Kim A; Potter JJ; Chen PH; Woreta TA
    World J Gastroenterol; 2022 Feb; 28(5):570-587. PubMed ID: 35316959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Features and Liver Injury in Patients with COVID-19 in the Japanese Population.
    Abe K; Yamamoto T; Matsumoto K; Kikuchi K; Miura R; Tachizawa N; Asaoka Y; Takezawa T; Matsunaga N; Obi S; Tanaka A
    Intern Med; 2020; 59(19):2353-2358. PubMed ID: 32999264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study.
    Weber S; Hellmuth JC; Scherer C; Muenchhoff M; Mayerle J; Gerbes AL
    Gut; 2021 Oct; 70(10):1925-1932. PubMed ID: 33514597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan.
    Zhang H; Liao YS; Gong J; Liu J; Zhang H
    World J Gastroenterol; 2020 Aug; 26(31):4694-4702. PubMed ID: 32884226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-19.
    Tripon S; Bilbault P; Fabacher T; Lefebvre N; Lescuyer S; Andres E; Schmitt E; Garnier-KepKA S; Borgne PL; Muller J; Merdji H; Chaffraix F; Mutter D; Baumert TF; Meziani F; Doffoel M
    Clin Res Hepatol Gastroenterol; 2022 May; 46(5):101894. PubMed ID: 35227956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.